European markets have spent most of the last two days consolidating the gains of the first two days of this week, with the FTSE100 set to close out the week, with its best weekly gain since January, and back where it was prior to the sell-off to the sell-off, in the wake of concerns over the Omicron variant.
Does that mean that Omicron's concerns are over? That’s a harder question to answer given the implementation of new restrictions across Europe, the UK and some parts of the US in response to higher infection rates. There is a concern that some governments are over-reacting, running the risk of making supply chain problems worse at a time when their economies are struggling to recover.
There appears to have been palpable relief that this afternoon’s US inflation numbers for November came in as expected, at 6.8%, which while still at a 39 year high, wasn’t nearer to some of the worst estimates which could have seen it rise above 7%. This appears to have helped put a floor under markets ahead of next week’s Fed meeting, although markets here in Europe appear to be softening into the close.
Today’s movers have been more defensive in nature with British American Tobacco leading the way building on its performance from earlier this week after it maintained its full-year guidance of constant currency revenue growth of above 5%.
Primark owner Associated British Foods today announced that like like sales compared to Q4 last year were trading ahead of expectations and that as far as full-year profits are concerned the retailer said it expected to make significant progress in operating profits and EPS.
US markets have picked up where they left off yesterday, opening higher after US CPI came in as expected, at 6.8%, its highest level since 1982. While this is still an awfully high number, and up from 6.2% in October, there is some relief it didn’t come in higher, above 7%, with US 2 year and 10-year yields slipping back.
The S&P500 is also now more or less back to where it was pre-Thanksgiving, prior to the Omicron sell-off.
Tesla shares have opened lower, as it transpires that CEO Elon Musk has sold another $963m in shares, bringing the total amount sold to almost $12bn over the last 5 weeks, with potentially another $5bn to go.
Moderna has also dropped sharply after initial trials of its flu vaccine showed positive results from early-stage trial data, however, the numbers weren’t that much different from other results from some of its competitors. Investors it would appear were looking for better outcomes so that the company isn’t seen as a one-trick pony.
The US dollar was initially lower in the aftermath of today’s US November CPI number which came in 6.8% and the highest level since 1982. There does appear to have been a collective sigh of relief that the number wasn’t higher, but its still likely to mean a higher US dollar in the longer term and reinforces the narrative that the Fed will probably have to go faster on a taper as we head into next year.
There was little in the way of a reaction to today’s UK GDP data for October which showed that the economy grew 0.1%, below expectations of 0.4%. The main drag was big falls in industrial production and construction output which fell 0.6%, and 1.8% respectively. Index of services rose 0.4% which was in line with expectations.
The Australian dollar has been the best performer this week along with the Canadian dollar after both central banks left rates unchanged, however, in both cases, we saw increasing concerns about the effects of inflation in both central bank outlooks. The RBA modified its guidance to suggest that a rate rise was likely to come sooner than expected, which wasn’t too much of a surprise, however market positioning was such that we’ve seen a sharp move back to the upside.
We’ve seen a solid rebound in crude oil prices this week, after hitting a three-month low last week and looks set to post its first positive week since October, breaking a run of 6 consecutive weekly declines. Saudi Arabia’s decision to raise prices at the start of the week, along with optimism over the long-term effects of Omicron has helped drive this week’s rebound, although it has been tempered by some end-of-week weakness on tighter restrictions.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 70.5% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money.
Follow us on Telegram
Stay updated of all the news
EUR/USD rises toward 1.0800 as USD weakens
EUR/USD has gained traction and advanced toward 1.0800 in the early American session on Monday. The positive opening witnessed in Wall Street makes it difficult for the US Dollar to find demand and helps the pair continue to push higher.
GBP/USD closes in on 1.2300 as mood improves
GBP/USD has preserved its bullish momentum and advanced to the 1.2300 area in the second half of the day on Monday. The risk positive market atmosphere makes it difficult for the US Dollar to stay resilient against its rivals and fuels the pair's daily rally. Eyes on BOE Governor Bailey's speech.
Gold: XAU/USD pared losses and consolidates around $1,950.00 Premium
Spot gold trades in the $1,950 price zone, sharply down on Monday as investors move away from safe-haven assets. The sentiment is positive at the start of the week amid easing concerns related to a global banking crisis.
MicroStrategy buys $150 million worth of Bitcoin as institutional interest soars to eight-month high
Bitcoin has been noting increasing institutional interest for the last few days as whale movement on the network grew.
US Consumer Confidence Preview: No good news for Americans Premium
The United States will publish the March Conference Board Consumer Confidence index, and market players anticipate it has contracted to 101 from 102.9 in February.